| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |